INTRODUCTION
The C-nucleoside antibiotics (Figure 1) constitute an important sub-group of microbial natural products with unusual structural features and diverse biological activities (Isono, 1988; Maffioli et al., 2017) . Their biosynthesis generally follows a succinct logic, with sequential modifications of simple precursors originating from primary metabolism (Hong et al., 2019; Isono, 1988; Palmu et al., 2017; Sosio et al., 2018; Wang et al., 2019) . Less typically, minimycin (MIN, also called oxazinomycin) is produced by diverse bacterial strains, either Streptomyces sp. or Pseudomonas sp., and shows prominent antimicrobial activities against both Gram-positive and Gram-negative bacteria Tymiak et al., 1984) . It has also demonstrated antitumor activity against transplantable tumors .
MIN is structurally similar to pseudouridine, a modified nucleoside that is found abundantly in tRNA (Li et al., 2016) . The MIN molecule has a unique structural feature in which a 1,3-oxazine 2,4-dione ring and a ribosyl sugar are linked via a C-glycoside bond (Sasaki et al., 1972) (Figure 1 ). Previous metabolic labeling studies have shown that the ribosyl portion of MIN derives directly from D-ribose (Isono and Suhadolnik, 1975, 1977) , and C-6, C-5, and C-4 of the oxazine ring arise from the corresponding C-3, C-4, and C-5 of L-glutamate (Isono and Suhadolnik, 1977) . Metabolic feeding experiments by Isono et al. showed that the C-2 of MIN is derived from carbon dioxide (Isono and Suhadolnik, 1975) . Concomitant chemical synthesis of MIN was also achieved, with the finding that the synthetic form of MIN shares identical biological features with that from microbial source (De Bernardo and Weigele, 1977) .
Indigoidine (Figure 1) is a bipyridyl pigment that was first documented as a microbial natural product in the 1960s (Kuhn et al., 1965) , and later discovered to be produced by surprisingly diverse microbes (Heumann et al., 1968; Starr et al., 1966) . The indigoidine biosynthetic gene cluster was initially reported from Dickeya dadantii (formerly known as Erwinia chrysanthemi), and it was revealed that it has important roles in pathogenicity and self-resistance to oxidative stress (Reverchon et al., 2002) . The gene for indigoidine biosynthesis was later identified from diverse Streptomyces strains (Novakova et al., 2010; Pait et al., 2017; Yu et al., 2013) . A single module non-ribosomal peptide synthetase (NRPS), which selectively recognizes L-glutamine as the starter substrate, was necessary for indigoidine biosynthesis (Brown et al., 2017; Takahashi et al., 2007) . The indigoidine NRPS gene was subsequently engineered as a promising tool for synthetic biology purposes, either for natural product discovery (Olano et al., 2014) or as a reporter system (Muller et al., 2012; Rezuchova et al., 2018; Xie et al., 2017) . More recently, Ankanahalli et al. have created a transgenic blue rose by introduction of a bacterial indigoidine biosynthesis gene (idgS) and a phosphopantetheinyl transferase gene (sfp) from surfactin biosynthesis (Nanjaraj Urs et al., 2019) .
In the present study, we address the biosynthesis of C-nucleoside MIN and indigoidine in Streptomyces hygroscopicus JCM 4712. We report that a minimal 5-gene cluster is essential for MIN biosynthesis and show that the divergent biosynthesis of MIN and indigoidine is mediated by an NRPS, MinA. Moreover, we reveal that the N-terminal phosphatase domain of MinC (called MinC N ), the MinD uracil phosphoribosyltransferase, and the MinT transporter are safeguard enzymes, which collaboratively constitute an unusual self-resistance system, in which MinD likely employs an unprecedented substrate-competition strategy for self-resistance by increasing the UMP pool in vivo. Our deciphering of the C-nucleoside MIN pathway expands current understanding regarding natural product biosynthesis and self-resistance.
RESULTS AND DISCUSSION

Identification of MIN Biosynthetic Gene Cluster from S. hygroscopicus JCM 4712
To identify the gene cluster responsible for MIN biosynthesis, the genome of S. hygroscopicus JCM 4712 was sequenced using the Illumina Hiseq 4000 method, which renders 8.8-Mb data (G + C content 70.31%) after assembly of clean reads. MIN contains a C-glycosidic bond that is structurally similar to that of pseudouridine and showdomycin (Palmu et al., 2017) (Figure 1 ), implying that they should employ similar enzymatic logic for C-glycosidic bond formation. We therefore utilize pseudouridine 5 0 -phosphate glycosidase YeiN (GenBank: CAQ32570.1) and C-glycosynthase SdmA (GenBank: KKZ73237.1) as query sequences to conduct individual BLASTP analysis, leading to the discovery of two homologs ORF5178 (designated as MinB, 46%/49% identities to YeiN/SdmA) (Table 1 ) and ORF3816 (46%/46% identities to YeiN/SdmA) from the genome of S. hygroscopicus JCM 4712 (GenBank: MN397911). On the genomic region surrounding minB is a closely linked gene coding for a non-ribosomal peptide synthetase (MinA) (Figure 2A ). The orf3816 gene is linked with a kinase gene (GenBank: MN397911), which is identical to the YeiN-YeiC cascade for the pseudouridine metabolic pathway in E. coli (Preumont et al., 2008) . These data suggest that the target region (min) covering minA and minB is likely to be involved in MIN biosynthesis.
To determine the identity of the min gene cluster, we directly cloned a ca. 11.2-kb region (likely housing the whole min gene cluster) using a two-step PCR strategy ( Figure S1A ; Tables S1 and S2). After confirmation ( Figure S1B ), the resultant plasmid pCHW301 was transferred into Streptomyces coelicolor M1154 (Gomez-Escribano and Bibb, 2014). The positive conjugants (S. coelicolor M1154::pCHW301) were then fermented Several C-nucleoside antibiotics (MIN-showdomycin, group I; pyrazofurin-formycin, group II; malayamycinpseudouridimycin, group III) shown are deduced to employ distinct enzymatic logics for the assembly of the C-glycosidic bond. The structure of indigoidine is highlighted in blue to represent its intrinsic color.
iScience 22, 430-440, December 20, 2019 431 for metabolite analysis. A bioassay indicated that the samples of M1154::pCHW301 show apparent inhibition against the indicator strain Bacillus subtilis, but the negative control (S. coelicolor M1154::pSET152) lacks related bioactivity ( Figure S1C ). High-performance liquid chromatography (HPLC) analysis showed that the sample of M1154::pCHW301 contains a new peak, which is absent from that of the negative control ( Figure S1D ). Further liquid chromatography-mass spectrometry (LC-MS) analysis shows that the LC peak is able to generate a characteristic [M + H] + ion at m/z 246.0609, with major fragment ions at m/z 155.9695, 210.1091, and 228.0699, fully consistent with the theoretical fragmentation pattern of MIN (Figures S1E-S1G).
To confirm the identity of the target metabolite accumulated by M1154::pCHW301, it was HPLC purified for 1D and 2D NMR analysis. As anticipated, the 1D NMR data of the target metabolite are closely matched to those of MIN ( Figures S2A and S2B ), and further detailed assignments of the compound as MIN are supported by 1 H-1 H COSY (Correlation Spectroscopy) and HMBC (Heteronuclear Multiple Bond Correlation) spectra (Figures S2C and S2D) . Analysis of the COSY NMR data led to the identification of a single isolated proton spin system corresponding to the ribose moiety (C-5 0 , C-4 0 , C-3 0 , C-2 0 , and C-1 0 ), from which the relative configuration was determined based on the analysis of coupling constants. The connection between the ribose moiety and (2H)-1,3-oxazine-2,4-(3H)-dione subunit was deduced from HMBC correlations of H-6 with C-1 0 ; H-1 0 with C-4 and C-6; and H-2 0 with C-5 (Table S3 ). Accordingly, the structure of the target metabolite was determined to be the same as that of MIN as shown. Taken together, these data demonstrate that the target gene cluster is responsible for the biosynthesis of MIN.
The Minimal 5-Gene (minTABCD) Cluster Is Essential for MIN Biosynthesis
In silico analysis revealed that the target 11.2-kb region (included in pCHW301) containing six genes is deduced to be involved in MIN biosynthesis. MinR shows 87% identity to SAMN05444521_6508 of Streptomyces sp. 3124.6, which is likely a FadR family transcriptional regulator. The second gene, minT, codes for an MFS transporter with high homology (79% identity) to SAMN05444521_6509 of Streptomyces sp. 3124.6 (Table 1) , which is proposed to transport the antibiotic out of the producer cell. The minA product displays significant homology (74% identities in total) to IndC, an NRPS protein from Streptomyces chromofuscus ATCC 49982, and the domain architectures of both enzymes are highly matched (Table 1) . MinB is shown to be homologous to IndA (pseudouridine-5 0 -phosphate glycosidase) with 88% identities (Table 1) . Moreover, in silico analysis shows that MinC possesses 77% identities to IndB of S. chromofuscus ATCC 49982 (Table 1) . Notably, minC encodes a 613-amino acid protein containing two domains, an N-terminal HAD phosphatase domain and the C-terminal DUF4243 domain with unassigned function. Concerning MinD, it shows 81% identity to Orf2 (uracil phosphoribosyltransferase) of S. chromofuscus ATCC 49982 (Table 1) .
To precisely pinpoint the minimal gene cluster for MIN biosynthesis, we individually mutated the target genes by an in vitro CRISPR-Cas9 system . After confirmation (Figures S3A and S3B; Tables  S2 and S4 ), the pCHW301 variants were conjugated into S. coelicolor M1154, and the resultant recombinants were fermented for further metabolite analysis. The antibacterial bioassay indicated that all the samples, with the exception for those of M1154::pCHW301 and M1154::pCHW301DminR, lack bioactivities against the Bacillus subtilis indicator strain ( Figure 2B ). Moreover, reverse-phase HPLC analysis indicated that the sample from M1154::pCHW301DminR could also produce the distinctive peak for MIN ( Figure 2C ), whose identity was further confirmed by LC-MS analysis ( Figures S3C-S3F ), suggesting that MIN biosynthesis is not under strict regulation by minR in S. coelicolor. These data demonstrate that a minimal 5-gene cluster (minTABCD) is essential for the maintenance of MIN biosynthesis.
Reconstitution of the MinA-Mediated Pathway for Indigoidine Biosynthesis
Bioinformatic analysis showed that MinA is a typical NRPS protein containing multiple A-Ox-T-TE-Tau domains ( Figure S4A ; Table 1 ). More surprisingly, MinA homologs had been previously characterized as the indigoidine synthetases (Takahashi et al., 2007) ( Figure 3A ), and we were therefore curious about how this enzyme is utilized to build MIN. To evaluate the functional role of MinA, the minA sequence was optimized on the basis of E. coli preference (Table S5) , and the resultant plasmid pET28a/minA* (*signifies the optimized sequence) was transferred into E. coli for protein overexpression and metabolite analysis. As anticipated, the broth of the E. coli recombinant showed a distinctive blue color (indigo) ( Figure 3B ), implicating the potential production of indigo dye. To further determine the identity of the blue pigment, a metabolite sample from the E. coli pET28a/minA* was submitted for HPLC assessment, generating a characteristic peak that was absent from the E. coli strain lacking minA* (negative control) ( Figures 3B, S4B , and S4C). (C) HPLC analysis of the metabolites produced by related recombinants of S. coelicolor M1154. Std, the authentic standard of MIN; pCHW301, the metabolites of the recombinant S. coelicolor M1154 containing pCHW301; DminA, the metabolites of the recombinant S. coelicolor M1154 containing pCHW301DminA, and other samples are correspondingly assigned; pSET152, the metabolites of the recombinant S. coelicolor M1154 containing pSET152 as negative control. The aliphatic numbers correspond to those in the bioassay plate. See also Figures S1-S3; Tables 1 and S1-S4. and S4E). Hence, this demonstrated that the single NRPS (MinA)-mediated pathway is sufficient to support indigoidine biosynthesis.
To reconstitute MinA activity in vitro, we over-expressed and purified the MinA protein from E. coli. The purified MinA shows bright yellow color ( Figures S4F and S4G ), a typical feature of a flavin-dependent protein, as confirmed by LC-MS analysis ( Figures S4H and S4I ). Enzymatic assays with the recombinant MinA produced an obvious blue color, implicating the production of indigoidine ( Figures 3C and 3D ), whose identity is further confirmed by LC-MS analysis ( Figure S4J ). The in vitro reaction without enzyme added (negative control) was unable to generate the blue-colored product, and the enzyme reactions in the absence of L-glutamine, ATP, or O 2 also generate similar negative results ( Figure 3D ). Furthermore, the purified MinA has only partial activity without an exogenous addition of FMN or Mg 2+ ( Figures 3D and S4K -S4M) and indicates the preference to relative low temperatures (18 C of all temperatures tested) ( Figures  S4N-S4P and S4R ). Subsequently, we tested the substrate flexibility for MinA against the unnatural isomer D-glutamine with negative result ( Figures S4Q and S4R ). These combined data substantially established that divergent biosynthesis of MIN and indigoidine is mediated by the NRPS (MinA) pathway, in which the compound 1 is likely converted to indigoidine via a non-enzymatic spontaneous reaction.
The potential pathways mediated by MinA homologs, as shown by in silico analysis, are actually more widely distributed than we initially imagined. In addition, there is also a high degree of diversity at the genetic level ( Figure S5 ). Earlier studies reported that indigoidine production affects the pathogenicity of the plant pathogen Dickeya dadantii (Reverchon et al., 2002) . In the present study, we tentatively propose that this bacterium could perform its pathogenic role by the coupled production of a potential MIN-related compound ( Figure S5 ), and it is of great interest for future study to elucidate such pathogenic mechanism at the molecular level. 
MinC N Is Responsible for the Final Dephosphorylation Step, and MinD Functions as a Uracil Phosphoribosyltransferase (UPRTase)
In silico analysis showed that MinC is a two-domain enzyme, consisting of an N-terminal phosphatase domain and a C-terminal domain of undefined function (we have not yet determine the characteristic properties of MinC C in the present study) ( Figures S6A and S6B ), and that in some cases these are separated into two independent proteins ( Figure S6A ). To determine if MinC N catalyzes the final dephosphorylation step ( Figure 4A ), we over-expressed and purified the protein from E. coli to near homogeneity ( Figure S6C ). This was assayed in vitro against the substrate MIN-MP, which is supplied by the Udk (uridine kinase from Bacillus subtilis, GenBank: QBJ70019.1) ( Bioinformatic analysis suggested that minD encodes an UPRTase, which are generally involved in the pyrimidine salvage pathway by catalyzing the reaction between uracil and phosphoribosylpyrophate (PRPP) to regenerate UMP (Singh et al., 2015) ( Figures 4C and S7A ). To investigate the enzymatic role of MinD, it was over-expressed and purified from E. coli ( Figure S7B ), and the corresponding activity was determined in vitro. As anticipated, HPLC analysis showed that the MinD-catalyzed reaction could generate a peak for UMP, corresponding to an authentic standard, which was absent from the negative control ( Figure 4D ). Further LC-MS analysis indicated that the target peak gave rise to a characteristic [M + H] + ion for UMP at m/z 325.0428, and main fragment ions at m/z 212.9202 and 227.0645, completely consistent with those of the UMP authentic standard ( Figures S7C-S7E ). These results establish that MinD functions as an UPRTase for the synthesis of UMP.
Divergent Biosynthesis of MIN and Indigoidine Is Mediated by an NRPS-Associated Assembly Line
Previous isotopic feeding experiments had showed that L-glutamate is incorporated into the oxazine ring of MIN (Isono and Suhadolnik, 1977; Suhadolnik and Reichenbach, 1981) , whereas its ribosyl moiety is from D-ribose (Isono and Suhadolnik, 1975) . In the present work, this mechanism is shown to be reasonable. MIN biosynthesis is confirmed to be initiated by MinA, which specifically selects L-glutamine as substrate, and the tethered amino acid is then dehydrogenated under strict and precise stereospecificity/regiospecificity at the C2-C3 positions by the oxidase domain (Ox domain). Subsequently, compound 1 is released by hydrolysis of the TE domain. Compound 1, as a key branch intermediate, is proposed to be converted to indigoidine by a spontaneous oxidative coupling reaction ( Figure 5 ). Simultaneously, this intermediate could be tautomerized by the Tau domain to form 2, which is modified by the MinB C-glycosynthase to produce 3. Compound 3 subsequently undergoes an unusual oxidative deamination and recombination reaction catalyzed by MinC C to generate MIN-MP, which is followed by the final dephosphorylation step to complete MIN biosynthesis ( Figure 5 ). MinC C features a DUF4243 domain, which is also present in a Baeyer-Villiger oxidase AflY of the aflatoxin biosynthetic pathway (Ehrlich et al., 2005) . In this respect, MinC C represents a novel type of Baeyer-Villiger oxidase catalyzing an unprecedented and intriguing oxidative deamination and recombination reaction, and relevant studies to investigate its enzymatic logic are now underway in our laboratory.
Indigoidine is a well-established microbial metabolite known for over half a century. However, it has now been established for the first time that this pigment is actually associated with the co-production of the C-nucleoside MIN. Accordingly, it is possible that indigoidine biosynthesis from an increasing number of potential pathways may be associated with related unknown C-nucleoside molecules, because analogs of the MinA-MinB pair are in several cases concomitantly present in the specific gene clusters ( Figure S5 ). L-glutamate is the common precursor for the aglycon of the C-nucleoside antibiotics, including MIN, formycin, pyrazofurin, and showdomycin (Suhadolnik and Reichenbach, 1981) , which until recently have been unexplored at the molecular level (Hong et al., 2019; Palmu et al., 2017; Sosio et al., 2018; Wang et al., 2019) .
Hence, we propose that further insight into the molecular logics underlying the biosynthesis of C-nucleoside antibiotics will identify diverse and unique enzymes for potential synthetic biology purposes. tentatively propose that it may play a key role in self-resistance during MIN biosynthesis by employing an unprecedented mechanism. We therefore introduced minD into S. coelicolor M1154 to determine whether it mediates a safeguard role. In contrast to this expectation, the recombinant strain (M1154::pIB139minD) had no apparent resistance to MIN (10 mg/mL). Accordingly, we re-examined the MIN gene cluster and noticed that minC N and minT are also potential contributors to the self-resistance system. To test the assumption, we individually introduced these two genes into S. coelicolor M1154. However, neither gene was capable of supporting the growth of the corresponding S. coelicolor M1154 recombinants in the presence of MIN (10 mg/mL, the minimal inhibitory concentration against S. coelicolor M1154-derived negative controls in this study) ( Figures 6A and 6B) . See also Figure S7 and Table S1.
These results suggested that some combination of minC N , minD, and minT may collaborate to fulfill the self-resistance role, and we accordingly introduced these different combinations into S. coelicolor M1154. Notably, several of these combinations are able to support the effective growth of the corresponding S. coelicolor M1154 recombinants in the presence of MIN, whereas the introduced single minC N , minD, or minT could not maintain the apparent growth of the related recombinants. It was also observed that minD has a greater contribution to the self-resistance system, and the combination (containing minC N , minD, and minT) could maintain the optimal growth status for the counterpart recombinant ( Figures 6A  and 6B ). Together, these data demonstrate that minD, in collaboration with minC N and minT, determines the functional role in vivo constituting the self-resistance system during MIN biosynthesis.
Biosynthesis of MIN Employs a Substrate-Competition Strategy for Self-Resistance
A further relevant question is how MIN executes its inhibitory role in vivo? We propose that similar to many other nucleoside analogs (Jordheim et al., 2013) , the phosphorylated form (MIN-MP) of MIN functions as the active inhibitory molecule. This is also supported by the discovery of kinases (from S. coelicolor M1154 and Bacillus subtilis) capable of recognizing MIN as substrates ( Figures S6C-S6H) , and the fact that MinD (UPRTase) may function as a safeguard enzyme by enhancing the in vivo UMP pool of microbial cells. To test this suggestion, we conducted bioassays using Bacillus subtilis as an indicator strain by exogenous addition of uridine and MIN at different concentration ratios. This strain showed resistance to MIN in the co-presence of relative high concentration of uridine ( Figure S7F ), implying that uridine, which is efficiently metabolized to UMP in vivo, is capable of partly alleviating the inhibition of MIN. Moreover, the in vivo UMP concentrations for the S. coelicolor M1154 recombinants, as determined by LC-high-resolution MS (HRMS), are considerably higher than those of the negative control (S. coelicolor M1154::pSET152) ( Figures 6C and S7G) , providing further support for the self-resistance model employed in MIN biosynthesis. In contrast, the in vivo MIN-MP (the active form of MIN), as indicated by LC-HRMS, is undetectable due to the relatively much lower concentration (if compared with that of UMP) ( Figures S7H and S7I) . These data support the hypothesis that the inhibitory role of MIN is attenuated by UMP by an unprecedented substratecompetition mechanism.
Biosynthetic bacteria have evolved several strategies for self-resistance during natural product production, often transporting the metabolite out of the producer cell upon its synthesis, or by modification of natural products or the target site (Wencewicz, 2019) . The substrate-competition strategy for self-resistance presented here is, to the best of our knowledge, unique, but it may be broadly exploited for microbial natural products biosynthesis. In this self-resistance system, the active inhibitory molecule MIN-MP is immediately dephosphorylated to form the end product MIN, most of which will be promptly transported out of the producer cells. MinD, therefore, functions as a safeguard enzyme that responds to sub-inhibitory concentrations of MIN-MP by increasing the UMP pool in vivo, thereby achieving the self-resistance for the producer cell ( Figure 6D ).
Limitations of the Study
In this study, we have uncovered that divergent biosynthesis of MIN and indigoidine is mediated by an NRPS enzyme and have demonstrated that an unprecedented collaborative self-resistance system is employed for MIN biosynthesis. However, the precise mechanism of how MIN executes its inhibitory role will require further study. Further studies will also be required to understand the enzymatic formation of the oxazine ring substituent of MIN.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND CODE AVAILABILITY
The DNA sequence is deposited in the GenBank database under individual accession numbers MK122964 (for the min gene cluster from S. hygrocsopicus JCM 4712) and MN397911 (for the genes orf3815 and orf3816 from S. hygrocsopicus JCM 4712).
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.11.037.
ISCI, Volume 22
Supplemental Information
Divergent Biosynthesis of C-Nucleoside Tables   Table S1. Strains and plasmids used in this study, Related to Figure 2-4 ATGAGCCCTCACGTTATTCCCCACACCCAGCGCGGTGACGTTTGTTTAACCGCACTGCTGGCCGAGCAG  GCGAGTGCAGCACCTCATAGAACCGCAGTTGTTCACGAAGACCAGAGCCTGACGTTTGCACAGCTGTT  AGATCATTCCAGATTATTAGGTGCACGTTTACGGCGTGCCGGTGTTACCCGTGGTAGTAGAGTTGGTG  TTTTTATGGAGCCGAGCCTGGAATTAATGACCAATGTTTGGGGTATTCTGTGGGCAGGTGGTAGCTAT  GTTCCGCTGAGCCCTGAATATCCGGAGGAACGTATTGCATATATGATGGCAGATGCAGGAGTTGAAGT  TGTTCTGACGCAGGAATTTCTGCGTTCACGTTTACAGGAGCTGTCACCGGCAGGTGTTCGTACCATTAC  CAGCGATGAGGTTTTTCATTCTGTTGAATCAGCGGATGAGGAGATTAGTAGTGCCGGCTTAGAGTCTT  GTCAGGCCGCACGTCCAGAAGATTTAGCATACGTTATTTATACAAGCGGCAGCACGGGGAAGCCGAA  AGGTGTTATGATTGAACATAGAAGCATCGTTAGCCAAATGCGGTGGCTGACCGAAGCATGTGGTATAG  ATGGGGGTCGTACCATTCTGCAGAAAACCCCGCTGAGCTTTGATGCCGCACAGTGGGAAATTTTAGCA  CCGGCATGCGGTAGCACAGTTGTAATGGGTGCACCGGGTATTTATCGTGATCCGGAAGCAATCGTTGC  CACCATTCAGAGACATGGTGTTACAACCTTACAGTGTGTTCCGACCTTACTTCAAGCCCTGCTGGACAC  CGAAACCTTAGCAGGTTGTGGTTCTTTACGTCAAGTGTTTTCTGGTGGTGAAGCGTTATCACGTAGTCT  GGCCGCCCAGTTTCTTGATACCATGCCGGATTGTAGTTTAGTTAATCTGTATGGCCCGACCGAGTGTAC  AATTAATGCAAGCGCATTTGTTGTTGATCGGACCGCTGTTGAAGATGGTCCGAGAGTTATGCCTATTGG  TACACCTGTTAGTGGTACCACCTTTCATGTTCTGGATAGCGCAGGTCGGGAGGCCACAGTAGGTGAAG  TTGGTGAACTGCACATTGGGGGGATTCAGGTTGCACGTGGGTATCTGGGGCGCCCTGATTTAACAGCA  GAACGTTTTGTTCAGGATACATTTAGCAGCGTTCCGGGTGCACGGCTGTATCGTACAGGTGATTTAGCA  CATTTTAATGCGGATGGTACAGTTCAATTTGTTGGTCGTACCGATAATCAGGTTAAACTGCGTGGGTAT  CGTGTTGAATTAGATGAAATTAGACAGGCCATTGAAACGCATGATTGGGTTCGTAGCAGTGCAGTTCT  GTTACGGGATGATGAAGCTACCGGGTTCCAAAATCTGGTTGCATTTGTTGAGCTGAATCCCAAGGAGG  CAGCATTAATGGATCAGGGTAATCATGGTGCACATCACCAGAGTAAACGTAGTAGACTGCAGGTTCGT  GCCCAGCTGAGCCATGCAGGTTGTCGTGATGCAGCAGATCTGGCAGGGCGTTCGGTCACAGCATTACC  GGGTGCAGAAGCAACCCCGGAACAGAGAGCAAGAGCATTTGCACGTAAAACCTATCGTTTTTATGAAG  GGGGTCAGGTTAGTCGGGAAGATATTCTGCGTTTACTGGCACCGCCGGGTAGACCTGGAGTTGCACCT  AGAAATCCGGGTAGCTTAAGTCGTGCAGAACTGGGTGGTATTCTGCGGAATTTTGGCCAGTATTTAAG  CGATCAGCGTCTGTTACCTAAATATGCATACGCTAGTCCGGGGAGTCTTTATGCAACCCAGTTATATTT  AGAACTTGATGGTATTGGGGGGATTGGTCCGGGTTTATATTATTATCACCCTTTACATCACCACTTAGT  GCTGATTGGCCCGACCCCGAGACAGTCTGGTCCTAGAGCATCCATTCATCTGCTGGGTAAACACAGTG  CAATTGAACCTGTTTATCGTAACAATATTCGTGAGGTTCTTGAAATTGAAGCAGGGCACATGGTTGGTT  TATTCGAAGAGGTTTTACCGGATTACGGTTTAGGTATTGCAGCAGAATATCGGCCGGCAGTTCTGCATC  GTCTGGAAGGTGCGGAAGAAGATCACTATTTAGGTACCATTGATCTGGTGCCGTATGATGCAAATGAA  AGCGCCGATGAGCTGGACATTTATGTGCAAGCACACGCAGGACGTGTTGATGGTCTGCGTGCAGGTC  AGTATCGTTATGCCGATGGCAGCTTAGTTCGTATTTCGGATGATTTAGTTCTGAAGAAACATGTTATCG  CGATTAATCAGCGTGTTTATGAGCGTGCGGGTCTGGGTATTAGTTTAGTTGCGACCGGTCCGGATTCAT  GGCGTCATTATCTGGATTTAGGGCGCAAGTTACAGCGTTTACAGATGAACGGGCTGAATTTAGGTTTT  ATGAGTAGTGGTTACAGCAGCAAGAGCGGTAATGACTTACCGGCGGCGAAACGTTTAAATCGTATTCT  GACAGATTGTGGGTTACCTACGGGTCCGTCGTATTTTTTTGTTGGTGGGCGGGTTAGCGATGAACAGT  TACGTGGTGAAGATATGAAAGAAGATGTTGTTCACATGCAGGGTCCGGCAGAACTGATTAAGGAGGA  TTTAGCAGGTCTGCTGCCGCGTTATATGCTGCCTAATAGAATTGTTGTGCTGGATCGTCTGCCGCTGAC  CGCAAATGGGAAAATAGACAGCAAAGCTCTTGAAGCCAGCCAGCAGGCGGATTTAGCATTAGCAGCA  AGAACCTTCATAGCACCGCGGACCCGTGTTGAACGGAGAGTACGTGATCTGTGGCAGACAGTGCTGA  AACAGGAACAGATAAGCGTGCGGGATGATTTTTTTGAGCTGGGGGGTAATAGCCTGCTGGCGGTTGC  ATTAGTTAATCGTATGAATAAAGCATTCGAGGGTACGGTTCCGCTGCAAGTGTTATTTGATGCCCCGAC  CGTTGAAAAGCTGGCCGCAAGACTTGATGCAGAACCTTCTGGTCCGTTAACCCGTCTGGTTCCGCTGCA  GCCTGAGGGTACAGGTACCCCTATTCATTGTTGGCCGGGTTTAGGTGGTTATCCGATGAATCTGAGAC  CGTTAGCAGCAGCACTTGGTAAAGATCGTCCGGTTCATGGTATTCAGGCACATGGGATTAATCGTGGC  GAAGATCCGTATGCGACCGTTCGTGAAATGGCGACCGCGGATGTTGAAGCAATTCGTAGTGCACAGCC  GGAAGGGCCTTATATTTTATGTGGCTATAGCTTTGGGGCACGCGTTGCATTTGAAGCCGCCAGACAGC  TGGAACAGGCGGGTCAACGTGTTGAGCATTTATTTTTAATTGCACCGGGTATGCCGCGTCTGCGTGAG  GAAGATACCGCAGGTCCGACCGGTAGAGCAGATTTTGCAGATCGGGCATTTGTGGCACTGCTGCATAG  TGTTTTTGCCGGTACCCTGAGCGGTCCGCAGTTAGATGATTGTTTAAGAACAGTTACCGATGAAGATAG   CTTTGTGGATTTTGTTACCAGCCGTTTTCCGGGTTTAGGTACCGAACTGGTTCAGGCAGTTACCGGTAT  TGTTAAACGTACCTATAGCCCGACCTACGAATTTCATGAACTGACCGGGCGTCGTCTGAACGCACCTGT  AACACTGGTTAAAGCAAATGACGATAATTATTCATTCATCGAACACCAGGATGCATTTTCAGTTAGACC  TCCGAGCGTGCATCAACTGCCTAGCGGTCATTATGAACTGCTGCGTGAACCACATGTTACCGAATTAGC  AGCACTGGTCAACGATCGCCTGCGCACAGCAGCAGGTAGCCCTTTTCCGGGTCAAGTGTCATTATCTCG  TGTTATTTCACAGGAGGCCGGTGTTCCGCATATTAATATTAAACATTTCCCAGTTGCCCTGAGCGAAGC  ACAGGAAAAAGAACTGCTGGCAGCCTTAACAAGCGCAGTCTCCAATGCATTTGGTTGTAAAGAAGATG TTGTGAGTATTGCCATAGAACCGGTCGAGCAAGAAGCATGGCACGAACGGGTGTATGAACCGGAAAT CGTACGTCGCCAGGATCTGCTGCGCAAAACCCCAAATTATTAA 
Supplementary
Transparent Methods
General methods
General methods employed in this work were according to the standard protocols of Green et al. (Green and Sambrook, 2002) or Kieser et al. (Kieser et al., 2000) .
Enzymes, chemicals, and reagents
All of the enzymes used in this study were purchased from New England Biolabs. The chemicals and reagents were the products of Sigma-Aldrich, Thermo Scientific, OMEGA, or J&K Scientific.
Sequencing analysis of S. hygroscopicus JCM 4712
Sequencing of the genomes of the strain was performed on an Illumina Hiseq2500 machine. The raw data were assembled by Velvet software (v1.2.07) to obtain the scaffold. The NRPS-PKS architecture was analyzed by PKS/NRPS analysis program (http://nrps.igs.umaryland.edu/) online. The detailed methods and programs used for genome annotations and accurate bioinformatic analysis were according to the protocols by Xu et al. (Xu et al., 2018) .
Fermentation and detection of MIN and related metabolites
For fermentation, S. hygroscopicus JCM 4712 was cultivated on MS medium (Murashige and Skoog, 1962) , and a single clone was inoculated in TSB medium (Murashige and Skoog, 1962) and cultivated for 36 hr. Subsequently, the cultures (2%, V/V) were transferred to fermentation medium (Bennett et al., 2009) .
Extraction and purification of MIN
The cultured broth was acidified to pH 4.0 with oxalic acid before filtration. The filtrate was collected, and extracted three times with an equal volume of ethyl acetate. The collected extract (under layer) was condensed and further dried by rotary evaporation and lyophilization. The dried residues were re-dissolved in methanol, and prepared by HPLC after passing through a 0.22 μm filter.
NMR analysis
NMR spectra of MIN were recorded on Agilent DD2 400 MHz NMR spectrometer, using D 2 O as solvent.
Bioassay of MIN
For MIN bioassay, Bacillus subtilis CGMCC 1.338 was used as indicator strain. After incubation in Luria-Bertani medium at 37°C for 12 hr, the strain (100 μl) was mixed into melted LA medium (20 ml). Related fermentation broth (40 μl) was added into the oxford cup, and the bioassay plate was cultivated at 37°C for 12 hr to observe the antibacterial zone.
Direct cloning of the whole min gene cluster
The whole min gene cluster was directly cloned by a two-step PCR strategy, and the detailed procedure is as follows: The two pieces (Left, Right, housing the whole min gene cluster were individually amplified by KOD plus polymerase (TOYOBO) with primers (piece1-F/R and piece2-F/R) (Table S2 ) and template (genomic DNA of S. hygroscopicus JCM 4712) ( Figure S1A ). Treated by related enzymes, the two pieces were simultaneously cloned into the XbaI-EcoRI sites of pSET152 to give pCHW301 (Fig. S1A) , which was confirmed by PCR with primers minid-F/R (Table S2 ).
In-frame deletion of the target min genes by in vitro CRISPR/Cas9 Editing (ICE) system
The target min genes were in-frame deleted by In vitro CRISPR/Cas9 Editing (ICE) system . For the construction of pCHW301 variants, the transcription templates were amplified by overlap extension PCR with primers listed in Table S2 .
Transcribed in vitro with the Transcript Aid T7 High Yield Transcription kit (Thermo;
Fisher Scientific), the prepared sgRNAs (10 μg) were added into a 50 μl reaction mixture containing Cas9 protein (3 μg), pCHW301 (3 μg), and 5 μl NEBuffer 3.1 (New England Biolabs) at 37°C overnight. The reaction was terminated by addition of 2 μl RNase (0.2 mg/ml, TIANGEN Biotech) and incubated at 37°C for 15 min. Then, the reaction mixture was treated with SDS (to 1%), 1 mg/ml proteinase K, and 10 mM CaCl 2 and incubated at 55°C for 30 min. The Cas9-digested DNA was recovered by phenol-chloroform extraction and ethanol precipitation. Finally, the prepared DNA was self-ligated by T4 DNA ligase (New England Biolabs), and the ligation mixture was finally transformed into E. coli.
Overexpression and purification of proteins
Genes minA and udk, optimized for E. coli preference, were synthesized (Synbio Tech) using pET28a as the expression vector. The optimized synthetic sequences are individually shown in Table S5 , S6. Expression and purification of MinA, Udk, Tdk, YeiC, MinC N , and MinD were carried out in a similar way as described by Wu et al. (Wu et al., 2017) . Purified proteins were concentrated and buffer-exchanged into protein stock buffer (25 mM Tris, 150 mM NaCl, and 10% glycerol, pH 7.0 for MinA, Udk, and Tdk, pH 7.5 for YeiC, MinC N , and MinD) using Amicon Ultra filters. The final proteins were flash-frozen in liquid nitrogen and stored at -80°C.
In vitro assay of MinA
For activity assay of MinA, reaction, consisting of 50 mM Tris buffer (pH 7.0), 1 mM L-Gln, 1 mM FMN, 5 mM MgCl 2 , 2 mM ATP and 20 µg MinA, was performed at 18°C (or other related temperature) overnight. Reaction was then terminated by addition of equivalent volume of methanol. Following centrifugation to remove the supernatant, 100 μl DMSO was added to dissolve the sediment. The reaction was analyzed by HPLC and LC-HRMS equipped with a reverse phase C18 column with 0.15% aqueous TFA (70%): methanol (30%) to 0.15% aqueous TFA (50%): methanol (50%) at a flow rate of 0.5 ml/min over 20 min.
In vitro assay of Udk, Tdk, YeiC, and MinC N For Udk (from Bacillus subtilis), Tdk and YeiC (from S. coelicolor) activity assay, reactions consisting of 50 mM Hepes buffer (pH 7.0), 1 mM MIN, 10 mM MgCl 2 , 1 mM ATP, and 20 µg protein was performed at 30°C. The reaction mixtures were added to ultrafiltration tube to remove protein by centrifugation after 4 hr, and the remaining reaction mixture was then collected. For MinC N activity assay, the FastAP buffer (Thermo Scientific) and 20 µg MinC N were added to the collected reaction mixture and incubated at 30°C. Reaction was terminated by the addition of methanol (equivalent volume) after 1 hr. Following centrifugation to remove protein, the reactions were analyzed by LC-HRMS equipped with a reverse phase C18 column.
In vitro assay of MinD
For activity assay of MinD, reaction consisting of 50 mM Tris buffer (pH 7.5), 1 mM 5-phosphoribose-1-pyrophosphate (PRPP), 10 mM MgCl 2 , 1 mM uracil, and 20 µg MinD, was conducted at 30°C. Reaction was terminated by the addition of equivalent volume of methanol after 4 hr. Following centrifugation to remove protein, the reactions were analyzed by HPLC equipped with a reverse phase C18 column with detection at 254 nm and a flow rate of 0.5 ml/min. The HPLC condition is as follows:
solvent system A (0.15% aqueous TFA) and B (methanol) run over a linear gradient of 90%-70% in 15 min.
The cloning and in vivo functional analysis of minD, minT, minC N
The recombinant plasmids (pIB139/minD, pIB139/minT, pIB139/minC N , pIB139/minDT, pIB139/minDC N , pIB139/minTC N , pIB139/minDTC N ) were constructed according to the standard protocols of Green et al. (Green and Sambrook, 2002) or
